Kyntra Bio Unearned Premium on Insurance Contract (Quarterly) Analysis

Kyntra Bio, Inc. (KYNB)

8.97 +0.23 (+2.63%) USD | NASDAQ | Jan 22, 16:00

View Unearned Premium on Insurance Contract (Quarterly) for KYNB.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Unearned Premium on Insurance Contract (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Unearned Premium on Insurance Contract (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Unearned Premium on Insurance Contract (Quarterly) Benchmarks

Start Trial

Assertio Holdings, Inc.	--
Perspective Therapeutics, Inc.	--
Skye Bioscience, Inc.	--
Theravance Biopharma, Inc.	--
Myomo, Inc.	--